PCOS Is Now PMOS: What the New Name Means for You

What is PMOS?

PMOS stands for Polyendocrine Metabolic Ovarian Syndrome. It is the new clinical name for what was called Polycystic Ovary Syndrome (PCOS). The renaming was published in The Lancet on 12 May 2026 and presented at the European Congress of Endocrinology in Prague. A coalition of 56 organizations supported the change, including the Endocrine Society, the International Androgen Excess and PCOS Society, the European Society of Endocrinology, and dozens of patient advocacy groups.

The new name keeps the "O" for ovarian, drops "polycystic" because many patients never have ovarian cysts, and adds two terms that describe what the condition actually does: polyendocrine (affects multiple hormone systems) and metabolic (affects how your body processes energy).

Why the name was changed

The old name described one feature (cysts on the ovaries) that many patients never have. The 2003 Rotterdam diagnostic criteria allowed a PCOS diagnosis without any ovarian cysts at all, as long as two of three conditions were present: irregular periods, high androgens, or polycystic ovary morphology. Roughly 30 percent of women with a PCOS diagnosis have no visible ovarian cysts. Naming a multisystem syndrome after a feature that misses a third of patients caused real harm.

The 2024 community survey of 14,952 patients and clinicians, run by the Endocrine Society as part of the renaming process, found that 86 percent of patients and 71 percent of clinicians supported a name change. The main reasons patients gave: doctors dismissed metabolic symptoms (insulin resistance, weight gain, blood sugar) as unrelated, dermatologists treated acne and hirsutism without checking hormones, and primary care providers told patients to "lose weight" without addressing the underlying endocrine driver.

The new name forces the clinical conversation to include all four affected systems: endocrine (hormones), metabolic (insulin and weight), reproductive (cycles and fertility), and dermatologic (skin and hair). Mental health is the fifth pillar that practitioners are now being trained to screen for under the PMOS framework.

What changes for you in 2026

The practical changes are small in the next 12 months. They compound over the next 3 to 5 years.

What changes immediately

• How clinicians refer to the condition. Endocrinologists and PCOS specialists have started using PMOS in clinic notes from May 2026 forward. Your records may show both names during the transition.
• New research papers and conference talks. Journals are updating style guides. Expect "PMOS (formerly PCOS)" in publications through 2026 and 2027.
• Insurance coding (US). ICD-10 code E28.2 still applies. A new ICD-11 code for PMOS is being drafted by WHO for 2027 release.

What changes over the next 2 to 3 years

• Medical school curricula. The condition will be taught as a multisystem endocrine disorder, not a reproductive one. New doctors will leave training already framing it correctly.
• Research funding. Funding bodies will reclassify the condition under endocrine and metabolic research streams, which historically receive larger budgets than reproductive health alone.
• Patient guidance. The Endocrine Society, the PCOS Awareness Association, and the International Androgen Excess and PCOS Society are rolling out new patient guides through 2026 and 2027.

What does not change

Your diagnosis, your symptoms, and your treatment do not change. The Rotterdam criteria for diagnosis are still in use. Metformin, inositol, and lifestyle interventions are still first-line. The 2023 International Evidence-based Guideline for the Assessment and Management of PCOS remains the standard of care until the next revision, expected in 2027 under the new name.

The dietary principles that help PCOS still help PMOS. A 30/30/40 macro split, calorie front-loading toward breakfast, 28 to 35g of fibre per day, and a Mediterranean-style fat profile reduce insulin and androgens regardless of what the condition is called. Our free 7-day PCOS meal plan applies these principles in plain, repeatable meals.

Why this matters beyond the label

Names shape diagnosis. A 2021 BMJ study on the effect of disease names on clinical decision-making found that conditions named after a single body part are diagnosed and treated more narrowly than conditions named for their mechanism. "Polycystic ovary syndrome" pointed clinicians at the ovaries. Many women got prescribed birth control to regulate cycles and were told that was the treatment, even when the bigger problem was insulin resistance, fatty liver, or pre-diabetes.

"Polyendocrine metabolic ovarian syndrome" points clinicians at the metabolism first. This matters because:

• Women with PCOS are 4 times more likely to develop type 2 diabetes than women without it, per the 2023 Lancet meta-analysis of 1.6 million women.
• Around 60 percent of women with PCOS have non-alcoholic fatty liver disease, often undiagnosed because the conversation focused on cycles.
• Women with PCOS have roughly double the lifetime risk of cardiovascular disease compared to age-matched controls.

These are the conditions the new name forces into the clinical conversation. The earlier they get screened for, the better the long-term outcome.

Should you update your records or tell your doctor?

No active steps are needed. Your existing diagnosis carries over. If you see a new clinician between now and 2027, they will recognise both names.

If you are starting a new specialist relationship, the simplest line is: "I have PCOS, now called PMOS. I would like a full metabolic screen (HbA1c, fasting insulin, lipid panel, liver enzymes) in addition to the hormone workup." Most endocrinologists are already doing this. If yours is not, the new name gives you a reason to ask.

About our name: we are staying PCOS Meal Planner

You will see the new name appear in journals, news headlines, and clinic notes through 2026 and 2027. The product you use, this site, the app, and the emails will keep the PCOS Meal Planner name for now.

The reason is practical, not stubborn. Around 2.3 million people search for "PCOS" each month in 2026. Almost no one yet searches for "PMOS." If we rename the site this week, we make it harder for the people who need us most to find us. The brand will move when patients use the new name in everyday conversation, not when journals and guidelines change. Best estimate: between 2028 and 2030.

Until then, every article we publish will reference both names where it helps clarify search intent. The food, the meal plans, the macros, the recipes, the support, all the same. A short and deliberate lag between the clinical name and the brand name while the world catches up.

Frequently asked questions

Is PMOS the same as PCOS?

Yes. PMOS (Polyendocrine Metabolic Ovarian Syndrome) is the new name for PCOS (Polycystic Ovary Syndrome), introduced 12 May 2026 after an 11-year consensus process. The diagnostic criteria, the symptoms, and the treatments are identical. The new name better reflects the multisystem nature of the condition.

When was PCOS renamed PMOS?

The new name was announced 12 May 2026 in The Lancet and presented at the European Congress of Endocrinology in Prague. A coalition of 56 patient and professional organizations, led by the Endocrine Society and the International Androgen Excess and PCOS Society, supported the change after surveying nearly 22,000 patients, clinicians, and researchers over 11 years.

Do I need to update my medical records to PMOS?

No action is required from you. Your existing PCOS diagnosis remains valid. Clinicians are gradually updating notes through 2026 and 2027. The ICD-10 code E28.2 still applies in the US until the new ICD-11 code is released, expected in 2027.

Will my treatment change under the PMOS name?

No. The 2023 International PCOS Guideline remains the standard of care until the next revision. First-line treatments (metformin, inositol, lifestyle interventions, hormonal contraceptives where indicated) are unchanged. The new name encourages broader metabolic and mental health screening but does not change the medications or the diet recommendations.

What does PMOS stand for?

PMOS stands for Polyendocrine Metabolic Ovarian Syndrome. "Polyendocrine" reflects involvement of multiple hormone systems. "Metabolic" reflects the insulin resistance and energy regulation pieces. "Ovarian" retains the reproductive component, even though many patients have no ovarian cysts.

Why was PCOS renamed?

The name "polycystic ovary syndrome" described a feature (ovarian cysts) that around 30 percent of patients never have, while ignoring the metabolic, dermatologic, and mental health components that most patients do have. The old name caused under-diagnosis and narrow treatment. 86 percent of patients and 71 percent of clinicians supported the change in the 2024 community survey.

Will PCOS Meal Planner change its name to PMOS Meal Planner?

Not yet. Most people in 2026 still search for "PCOS" rather than "PMOS." The brand will rename when patients use the new name in everyday conversation, likely between 2028 and 2030. The product, the app, and the meal plans stay the same. Articles will reference both names during the transition.

Will doctors still use the term PCOS?

Yes, during the transition. Many doctors will use both names. Insurance coding (ICD-10) still says polycystic ovary syndrome until the ICD-11 update expected in 2027. New medical school curricula and 2027 guidelines onward will teach PMOS as the primary name.

Try the meal planner

What to read next

• PCOS (PMOS) 101: complete guide to symptoms, types, and treatment
• Insulin resistance meal plan for PCOS
• Free 7-day PCOS meal plan built by a registered dietitian
• Inositol vs metformin for PCOS

Sources

• Endocrine Society. "Polyendocrine Metabolic Ovarian Syndrome: new name to improve diagnosis and care of condition affecting 170 million women worldwide," 12 May 2026.
• The Lancet. PCOS renaming consensus paper, 12 May 2026.
• STAT News. "PCOS is now called PMOS. The renaming process lasted a decade," 12 May 2026.
• Healthline. "PCOS Is Renamed PMOS. Doctors Say It Will Improve Diagnosis, Treatment," May 2026.
• 2023 International Evidence-based Guideline for the Assessment and Management of PCOS.
• 2024 PCOS Renaming Community Survey (n=14,952), Endocrine Society and partners.
• BMJ 2021 study on disease names and clinical decision-making.
• Lancet 2023 meta-analysis on PCOS and type 2 diabetes risk.

How this article was written

This explainer was written within 11 days of the official PCOS to PMOS renaming announcement on 12 May 2026, drawing on the Endocrine Society press release, The Lancet renaming consensus paper, and coverage in STAT News, Healthline, CNN, and AJMC. The dietary recommendations referenced are unchanged from the 2023 International PCOS Guideline. See our editorial standards.